1. Home
  2. HZO vs ATTO Comparison

HZO vs ATTO Comparison

Compare HZO & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

SELL

Current Price

$52.45

Market Cap

1.2B

ML Signal

SELL

Logo Attovia Therapeutics Inc. Common Stock

ATTO

Attovia Therapeutics Inc. Common Stock

N/A

Current Price

$13.67

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HZO
ATTO
Founded
1998
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1998
2026

Fundamental Metrics

Financial Performance
Metric
HZO
ATTO
Price
$52.45
$13.67
Analyst Decision
Hold
Strong Buy
Analyst Count
9
5
Target Price
★ $49.40
$42.20
AVG Volume (30 Days)
★ 692.1K
401.1K
Earning Date
11-12-2026
09-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.21
N/A
Revenue
★ $2,309,288,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.38
N/A
P/E Ratio
$250.60
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$21.42
$12.94
52 Week High
$52.65
$28.00

Technical Indicators

Market Signals
Indicator
HZO
ATTO
Relative Strength Index (RSI) 60.56 30.07
Support Level $52.16 $12.94
Resistance Level $52.45 $15.54
Average True Range (ATR) 0.15 1.24
MACD -0.11 -0.05
Stochastic Oscillator 72.22 13.25

Price Performance

Historical Comparison
HZO
ATTO

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About ATTO Attovia Therapeutics Inc. Common Stock

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Share on Social Networks: